| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,957 |
3,729 |
$370K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
6,820 |
5,446 |
$232K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,399 |
4,280 |
$231K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,080 |
2,080 |
$174K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,855 |
1,843 |
$149K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,605 |
1,605 |
$134K |
| 90461 |
|
2,488 |
2,481 |
$96K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,598 |
1,590 |
$82K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
6,561 |
6,550 |
$59K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
576 |
576 |
$52K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
4,435 |
4,295 |
$51K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,338 |
1,330 |
$34K |
| 99188 |
|
1,192 |
1,191 |
$31K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,071 |
4,051 |
$30K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
330 |
330 |
$25K |
| 96127 |
|
2,236 |
2,230 |
$23K |
| 99177 |
|
1,287 |
1,286 |
$23K |
| 36416 |
|
1,926 |
1,904 |
$19K |
| 99215 |
Prolong outpt/office vis |
115 |
113 |
$15K |
| 83655 |
|
1,024 |
1,024 |
$12K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
389 |
389 |
$12K |
| 80061 |
Lipid panel |
713 |
695 |
$9K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
240 |
239 |
$5K |
| 0071A |
|
71 |
71 |
$3K |
| 0072A |
|
70 |
70 |
$3K |
| 99050 |
|
181 |
181 |
$3K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
82 |
82 |
$2K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
82 |
82 |
$2K |
| 0001A |
|
46 |
46 |
$2K |
| 99051 |
|
126 |
126 |
$2K |
| 0002A |
|
38 |
38 |
$2K |
| 87634 |
|
20 |
20 |
$1K |
| 92587 |
|
44 |
44 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
452 |
442 |
$1K |
| 94760 |
|
403 |
392 |
$892.54 |
| 99173 |
|
39 |
39 |
$866.58 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
56 |
55 |
$661.36 |
| 0124A |
|
13 |
13 |
$596.44 |
| 81003 |
|
254 |
252 |
$533.35 |
| 83718 |
|
60 |
60 |
$507.00 |
| 0054A |
|
13 |
13 |
$455.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
18 |
17 |
$425.16 |
| 82465 |
|
60 |
60 |
$268.80 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
15 |
15 |
$228.90 |
| 87081 |
|
28 |
27 |
$191.52 |
| 99000 |
|
97 |
96 |
$97.00 |